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CD8+ T cell killing of tumor cells is suppressed by the tumor microenvironment and increased expression 
of inhibitory receptors, including programed cell death protein-1 (PD-1), is associated with tumor-
mediated T cell suppression. To discover cellular defects triggered by tumor exposure and associated PD-
1 signaling, we established an ex vivo imaging approach to investigate the response of antigen-specific, 
activated effector CD8+ tumor infiltrating lymphocytes (TILs) after interaction with tumor targets. 
Whereas TIL-tumor cell couples formed, couple stability deteriorated within minutes. This was associated 
with impaired F-actin clearing from the center of the cellular interface, reduced calcium signaling, 
increased TIL locomotion and impaired tumor cell killing. Interaction of CD8+ lymphocytes with tumor cell 
spheroids in vitro induced a similar phenotype, supporting a critical role of direct  T cell tumor cell contact. 
Diminished engagement of PD-1 within the tumor, but not acute ex vivo blockade, partially restored cell 






Cancer cells are commonly recognized by the immune system and immune cells constitute a large part of 
the tumor mass. Cytotoxic T lymphocytes (CTL) are capable of directly killing cancer cells. However, their 
killing ability is widely suppressed after they have entered the tumor, where they are known as tumor 
infiltrating lymphocytes (TIL). A number of key contributors to in vivo tumor-mediated immune 
suppression have been characterized. Most prominently, tumor-reactive T cells increase expression of 
inhibitory receptors, including cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), PD-1, lymphocyte 
activation gene 3(LAG3), T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-
based inhibitory motif domains (TIGIT) and T cell molecule with immunoglobulin and mucin domain 3 
(TIM3) (1, 2). Monoclonal antibody blockade of CLTA-4 and PD-1 has yielded substantial clinical success in 
enhancing the anti-tumor immune response (3). Additional mechanisms of tumor-mediated immune 
suppression include recruitment of tolerogenic immune cells, notably regulatory CD4+ T cells (Tregs) into 
the tumor (4, 5) and the expression of suppressive soluble mediators, such as adenosine and 
prostaglandin-E2 (PGE2)(6-8). While it is clear that tumor cell killing is diminished due to the 
immunosuppressive tumor microenvironment it is still uncertain as to which cellular steps in tumor target 
cell killing are impaired in TILs and how such impairment is controlled by the established mediators of 
tumor-mediated immune suppression.   
 
PD-1 is a critical mediator of tumor-mediated immune suppression and is upregulated in response to 
continuous antigen exposure. In persistent viral infections PD-1 signaling maintains an exhausted 
phenotype among CD8+ T cells (9). PD-1 engagement has multiple effects on T cell activation. These 
include activation of phosphatase and tensin homolog (PTEN) (10), recruitment of the phosphatase 
sarcoma homology 2 domain phosphatase 2 SHP-2 (11, 12), suppression of sustained activation of Akt and 
Ras pathways with consequences for cell cycle regulation (13), inhibition of glycolysis along with 
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promotion of lipolysis and oxidative metabolism (14) and upregulation of the proapoptotic protein Bim 
(15). PD-1 engagement inhibits the T cell stop signal upon antigen presenting cell contact (16) and the 
formation of stable cell couples (17). However, it remains unresolved as to whether and if so, how PD-1 
signalling disrupts the cellular events required for CTL killing.  
 
The killing of target cells by CTLs requires carefully orchestrated steps of cellular reorganization 
(‘polarization’). CTLs must bind to the target cells, use actin polymerization to stabilize the cellular 
interface, relocate the MTOC from behind the nucleus to the center of the cellular interface, and finally 
release the contents of cytolytic granules directed towards the target cell (18, 19). The elevation of the T 
cell cytoplasmic calcium concentration as mediated by store-operated calcium entry using the ER calcium 
sensor STIM and the plasma membrane calcium channel Orai is a key signaling step required for cytolytic 
granule release (20). Elevation of the TIL intracellular calcium concentration is diminished as likely driven 
by defects in proximal TCR signal transduction. Demonstrating the importance of calcium signaling for CTL 
function and tumor control, loss of or mutations in STIM and Orai impair cytolytic killing and immune 
control of tumors and activation of calcium channels in CD8+ T cells can restrain tumor growth (21-25). 
The elevation of the T cell cytoplasmic calcium concentration and actin dynamics are bi-directionally 
linked (26). 
 
To investigate how T cell polarization and related signaling are altered when TILs interact with their tumor 
target cells, we have adapted a well-established model of antigen-driven tumor recognition to ex vivo live 
cell imaging approaches. A renal carcinoma cell line (Renca) expressing the influenza virus haemagglutinin 
(HA) as a neo-antigen (RencaHA) is recognized by CD8+ T cells from Clone 4 TCR transgenic mice (27). 
When adoptively transferred into a RencaHA-tumor bearing BALB/c mouse naïve Clone 4 T cells are 
primed within the tumor-draining lymph nodes, infiltrate the tumor and acquire a suppressed phenotype 
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that is characterized by diminished cytokine secretion, killing ability and enhanced inhibitory receptor 
expression (28). Here we have adoptively transferred in vitro activated Clone 4 CD8+ T cells into RencaHA 
tumor-bearing mice. These transduced Clone 4 T cells homed to the tumor and acquired a suppressed 
phenotype. They were reisolated for an ex vivo investigation of their interaction with RencaHA tumor 
cells. Clone 4 TILs displayed impaired cell couple maintenance with their tumor targets that was associated 
with impaired F-actin distributions at the target cell interface and reduced calcium signaling, resulting in 
impaired tumor cell killing. PD-1 expression on Clone 4 TILs was elevated. Direct interaction of Clone 4 T 
cells with RencaHA tumor cell spheroids in vitro induced a similar phenotype.  Blocking PD-1 engagement 
in vivo in the tumor microenvironment, but not acutely in vitro, enhanced tumor clearance and improved 
the maintenance of TIL cells. Thus, we have we have discovered a cellular mechanism of tumor-mediated 
immune suppression: Impaired maintenance of T cell polarization diminished TIL killing ability and was 
regulated by the inhibitory receptor PD-1. 
 
Results 
The cytolytic ability of CD8+ T cells is diminished by tumor infiltration 
To investigate the killing of tumor target cells by CD8+ TILs, we adapted a mouse model of neo-antigen 
CD8+ T cell tumor recognition to enable ex vivo live cell imaging approaches (Fig. 1A). RencaHA renal 
carcinoma cells express the haemagglutinin (HA) protein from influenza A/PR/8/H1N1 as a neo-antigen. 
The Clone 4 TCR recognizes the dominant H2- Kd –restricted HA peptide 518-526 (IYSTVASSL). In all 
experiments, CD8+ T cells from Clone 4 TCR transgenic mice were activated in vitro with HA peptide-pulsed 
splenocytes and retrovirally transduced to express GFP-tagged proteins of interest. Cells were FACS sorted 
to ensure sensor abundance was close to endogenous protein amounts (29, 30). Activated, transduced 
Clone 4 CD8+ T cells were adoptively transferred into BALB/c mice bearing established subcutaneous 




To explore the cytolytic capability of tumor-specific CTLs and TILs, we developed an imaging-based ex vivo 
killing assay. Renca cells plated in a glass-bottom imaging plate were pulsed with HA peptide (Renca+HA) 
and were then overlayed with Clone 4 CTLs or TILs. We found that CTLs efficiently lysed target cells, 
decreasing the imaging area covered by Renca+HA cells at a rate of 8±3 %/h (Fig. 1, B to D). Similarly, Clone 
4 CTLs specifically lysed BALB/c splenocytes pulsed with HA peptide in vivo (fig. S1) . Non-HA peptide-
pulsed Renca cells continued to proliferate, which confirmed that lysis was dependent on cognate antigen 
recognition. In contrast, Clone 4 TILs were poorly cytolytic, as expected (39, 45, 56). The area covered by 
Renca+HA cells was cleared at a significantly reduced rate of 3±1 %/h (Fig. 1, B to D).  
 
TIL MTOC polarization and cell couple maintenance is impaired 
In cytotoxic T cells, relocation of the MTOC from behind the nucleus to the target cell interface after cell 
coupling is critical for lytic granule release and cytolytic activity (31). To visualize CD8+ T cell MTOC 
polarization toward the Renca target cell interface, tubulin-GFP transduced HA-specific Clone 4 CTLs and 
TILs were imaged during their interaction with Renca+HA cells by spinning disk confocal microscopy. 
Whereas all CTLs relocated the MTOC to the cellular interface within 7min, fewer TILs quickly relocated 
their MTOC towards the tumor cell contact site (Fig. 2, A to C, fig. S2, movie S1).  
 
We also investigated Clone 4 CD8+ T cell-target cell coupling and morphology and found that TILs formed 
tumor cell couples less frequently than CTLs. Whereas the initial contact of Clone 4 TILs with Renca+HA 
target cells led to the formation of tight cell couples in 31±6% of contacts, 78±3% of Clone 4 CTL-tumor 
cell contacts led to the formation of tight couples . Clone 4 CTLs formed symmetrical, stable interfaces 
with Renca+HA target cells throughout 12 minutes of observation (Fig. 2D). Initial immune synapses 
between Clone 4 TILs and Renca+HA target cells were also symmetrical, but polarization was diminished 
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starting as rapidly as seconds after tight cell coupling (Fig. 2E). To quantify this difference in Clone 4 CD8+ 
T cell polarization, we determined the occurrence of lamellae pointing away from the cellular interface 
(red arrow, Fig. 2E). T cells continuously extend large lamellae, but whilst directing such lamellae towards 
the interface is expected to be stabilizing, directing them away from the interface (‘off-synapse lamellae’) 
may weaken it (32, 33). Off-synapse lamellae occurred in a higher proportion of TILs than CTLs (Fig. 2F) 
and were observed earlier during cell coupling (Fig. 2G). Furthermore, TILs remained at the initial site of 
target cell binding less efficiently: 14±3% of TILs translocated across the target cell surface by at least one 
interface diameter from the initial site of target cell binding, whereas only 4±2% of CTLs translocated (Fig. 
2H), as expected (34, 35). Thus our data indicate  that although HA-specific TILs could effectively establish 
cell couples with peptide-pulsed Renca target cells, they did not maintain cell couples well.  
 
Peripheral F-actin ring formation is destabilized in TILs  
The immunological synapse is stabilized by an F-actin ring around its periphery. In cytolytic killing 
clearance of F-actin from the interface center can be associated with effective secretion of cytolytic 
granules (36), but doesn’t have to be (37, 38). To determine whether impaired F-actin distributions could 
underpin impaired maintenance of TIL cell couples, we visualized F-actin with an F-actin-binding peptide 
conjugated to GFP, F-tractin-GFP (39). Clone 4 CTLs and TILs expressing F-tractin-GFP were imaged (Figs. 
3, A to C), and the data were automatically shape-normalized and computationally analyzed (Figs. 3D and 
E, fig. S3A,movie S2). To investigate F-actin clearance from the interface center, we measured the ratio of 
F-actin accumulation at the interface center relative to the entire cell (Fig. 3D). At the time of first Clone 
4 T cell contact with Renca+HA target cells F-actin was comparably enriched in CTLs and TILs. However, F-
actin enrichment at the interface center rapidly decreased in Clone 4CTLs to 1.3-fold or less over the next 
two minutes indicative of central clearing. In contrast, F-actin enrichment remained above 1.5-fold in 
Clone 4 TILs. Addressing F-actin distributions cell-wide, we measured enrichment in the 10% of the cell 
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volume with the highest F-tractin amounts, which largely corresponded to the cellular interface with an 
emphasis on its edge (Fig. 3D). Enrichment of F-actin was increased in antigen-specific TILs relative to CTLs 
(Fig. 3E). However, as TILs display substantially reduced F-actin amounts overall, as determined by 
phalloidin staining (fig. S3, B and C). Thus, the increased relative interface enrichment in Clone 4 TILs was 
unlikely to correspond to higher F-actin densities, which suggests that the dominant F-actin defect in 
Clone 4 TILs was impaired F-actin clearance from the interface center.  This defect just preceded the time 
of occurrence of off-interface lamellae (Fig. 2G) and the time at which MTOC polarization began to fail 
(Fig. 2C).  
 
To investigate whether impaired cell couple maintenance can result in loss of cytolytic effector function, 
Clone 4 CTLs were treated with a low concentration of Jasplakinolide, a macrocyclic peptide that promotes 
actin filament nucleation. At this concentration, cell coupling was not substantially impaired but F-actin 
turnover was slowed (40, 41). Interface F-actin accumulation was slightly diminished after Jasplakinolide-
treatment, as the 10% cell volume with the greatest F-tractin amounts were not exclusively focused on 
the interface any more, but included regions at the T cell distal pole (Fig. 3E). Treatment with 
Jasplakinolide significantly reduced the rate of target cell lysis by CTLs to levels displayed by TILs (Fig. 3F). 
Treatment of Clone 4 CTLs with a higher concentration of Jasplakinolide that impairs cell coupling (41), 
further reduced killing (Fig. 3F). The similar phenotypes of Jasplakinolide-treated Clone 4 CTLs and TILs 
suggest that tumor-induced disruption of actin remodeling may suppress TIL lytic activity.  
 
Interface recruitment of negative regulators of F-actin is more extensive in TILs 
T cell actin remodeling is a dynamic process, which is promoted by the Arp2/3 complex. Coronin 1A and 
cofilin inhibit the Arp2/3 complex and promote the severing and depolymerisation of F-actin, respectively. 
Actin regulators need to localize to regions of T cell F-actin turnover to be effective (30). To investigate 
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mechanisms of altered F-actin dynamics, Clone 4 CTLs and TILs that were transduced with either cofilin-
GFP, Arp3-GFP, or Coronin 1A-GFP were imaged (Fig. 4, A to G, fig. S4, A to G, movies S3 to S5). Although 
we found no difference in Arp3 interface recruitment between Clone 4 CTLs and TILs, interface 
recruitment of cofilin and Coronin1A was enhanced in Clone 4 TILs within seconds of tight cell coupling, 
as compared with Clone 4 CTLs (Fig. 4F). These differences in  cofilin and Coronin 1A interface enrichment 
persisted after prolonged tight cell coupling (Fig. 4G). The distribution of the cofilin-activating 
phosphatase Chronophin (42) was similar to that of cofilin itself (Fig. S4, H to K, movie S6). To establish 
whether the increase in cofilin interface enrichment was associated with enhanced cofilin activation, we 
determined the amounts of active, i.e. non- phosphorylated, cofilin by phos-tag western blotting of Clone 
4 CTL and TIL lysates activated on anti-CD3 antibody-coated plates. At all of the time points, the 
percentage of active, unphosphorylated cofilin was increased within TILs when compared to CTLs (Fig. 4H 
and I, fig. S5A). However, the overall abundance of cofilin was reduced in Clone 4 TIL when compared to 
CTLs, as determined by Western blotting (fig. S5B). The increased interface retention of cofilin and Coronin 
1A in TILs after cell coupling suggests that impaired TIL F-actin stability could underpin the diminished F-
actin translocation to the edge of the interface (Fig. 3D) and the accompanying defect in cell couple 
maintenance (Fig 2, D and E) that we observed earlier. 
 
Activation-induced cytoplasmic calcium influx is impaired in TILs 
To identify signaling defects associated with TIL polarization impairment, we also investigated the T cell 
cytoplasmic calcium concentration in Clone 4 T cells after activation by Renca+HA APCs with the calcium-
sensitive, ratiometric fluorescent dye Fura-2 (Fig. 5, movie S7). In Clone 4 CTLs the cytoplasmic calcium 
concentration rose rapidly after initial APC contact, often following formation of a first small membrane 
contact. In contrast, after activation the cytoplasmic calcium concentration increase in Clone 4 TILs was 
delayed sometimes up to minutes and greatly reduced (Fig. 5, C and D), as expected (21, 24, 25). To 
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determine whether the calcium signaling defect could be linked to impaired killing and cell couple 
maintenance, we treated HA-specific CTLs with Ni2+ to block plasma membrane calcium channels and 
BAPTA to buffer cytoplasmic calcium. Killing of Renca+HA target cells was 5.8±0.3% area shrinkage/h 
without treatment in our imaging-based killing assay and 2.9±1.0% after Ni2+ + BAPTA treatment (Fig. 5E). 
This treatment reduced the frequency of tight cell couple formation between Clone 4 TILs and Renca+HA 
target cells from 78±3% without treatment to 34±7% after Ni2+ + BAPTA treatment (Fig 5F). Whereas 
80±7% of CTLs treated with Ni2+ and BAPTA produced off-synapse lamellae, only 24±4% of untreated CTLs 
did (Fig 5G) although the onset time did not differ (Fig. 5G). Similarly, 29±8% of CTLs treated with Ni2+ and 
BAPTA translocated over the target cell surface by at least a full interface diameter, but only  4±2% of CTLs 
translocated over the same distance (Fig. 5G). These data suggest that diminished calcium signaling could 
contribute to impaired cell couple maintenance in TILs (Fig. 5H). 
 
Direct interaction between CTLs and tumor cell spheroids induces the polarization-impaired state 
To determine whether infiltration of CTLs into three-dimensional tumor cell structures was sufficient to 
impair polarization of CD8+ T cells, we grew Renca cells as spheroids in Matrigel. Overnight interaction of 
Clone 4 CTLs with spheroids incubated with HA peptide (Fig. 1A) resulted in Clone 4 infiltration to generate 
spheroid-infiltrating lymphocytes (SILs)(Fig. 6A). After re-isolation from the spheroids, we found that 
killing of Renca+HA target cells was reduced from 5.6±0.7% area shrinkage/h after co-culture with activated 
CTLs to 3.5±0.9% after co-culture with SILs (Fig. 6B). Similar to TILs (Fig. 7A), PD-1 abundance was 
increased in SILs when compared to CTLs (Fig. 6C). Additionally, the frequency of the formation of tight 
cell couples after initial SIL contact with Renca+HA target cells was reduced when compared to that of Clone 
4 CTLs, and the maintenance of SIL couples with Renca+HA cells was impaired (Fig. 6D). Finally, the 
cytoplasmic calcium concentration was substantially reduced after activation of SILs (Fig. 6E). Thus, 
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infiltration of Clone 4 CTLs into Renca spheroids induced a polarization impaired state that shared critical 
features with functionally impaired TILs.  
 
Blocking PD-1 in vivo enhances TIL killing and tumor rejection 
To identify potential in vivo regulators of the diminished maintenance of TIL cytoskeletal polarization, we 
investigated the role of PD-1. The expression of PD-1 limits anti-tumor immunity (1, 3) and we confirmed 
that the abundance of PD-1 was increased on TILs and endogenous CD8+ T cells from RencaHA tumors 
when compared to activated CTLs (Fig 7A). When RencaHA tumor-bearing mice were treated with a 
monoclonal blocking antibody (mAb) against PD-1 for 6 days before and after adoptive transfer of Clone 
4 CTLs (Fig. 7B), we confirmed that tumor growth was significantly reduced after antibody treatment when 
compared to control treated mice (Fig. 7C), as expected (3). In addition, killing of Renca+HA tumor cells ex 
vivo by Clone 4 TILs isolated from anti-PD-1 treated mice was substantially enhanced (Fig. 7D). 
 
PD-1 inhibitory signaling is activated by engagement of its ligand PD-L1, which is expressed on tumor cells 
and/or tumor-associated immune cells (1). To investigate the functional relevance of tumor-expressed 
PD-L1, a RencaHA-PD-L1-/- cell line was generated (fig. S6A). Loss of PD-L1 expression induced spontaneous 
tumor regression in 4/10 mice, and increased survival (fig. S6, B and C). In combination with adoptive 
transfer of HA-specific Clone 4 CTLs, all mice bearing RencaHA-PD-L1-/- tumors underwent complete tumor 
clearance, compared to only 1/7 control mice (Fig. 7, E and F). Thus,  PD-L1 on RencaHA cells greatly 
contributes to suppression of adoptively transferred Clone 4 CTLs. In combination, the experiments with 
PD-1 blocking antibodies and PD-L1-deficient tumor cells establish that PD-1 is a critical element of in vivo 
tumor immune suppression in the RencaHA model. 
 
PD-1 promotes the impaired maintenance of TIL polarization in vivo 
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To investigate whether blockade of PD-1 engagement within the tumor microenvironment restores TIL 
polarization, we studied TILs isolated from RencaHA tumor-bearing mice treated with antibody against 
PD-1 or from RencaHA-PD-L1-/- tumor-bearing mice ex vivo. Upon treatment with PD-1 blocking antibodies 
or use of RencaHA-PD-L1-/- tumors 9±5% and 11±5% of TILs, respectively, displayed translocation of at 
least one interface diameter over the target cell surface following immune synapse formation as 
compared to 14±3% in buffer only-treated TILs (fig. S7A). The production of off-synapse lamellae was not 
reduced by PD-1 blockade (fig. S7, B and C). In TILs from mice treated with antibodies against PD-1, or TILs 
from RencaHA-PD-L1-/- tumor-bearing mice, F-actin clearing from the interface center was significantly 
enhanced at multiple time points and closely resembled that of Clone 4 CTLs (Fig. 8A, and fig. S7D). 
Similarly, cofilin interface accumulation was not enhanced in Clone 4 TILs from mice treated with antibody 
against PD-1 or mice with RencaHA-PD-L1-/- tumors (Fig. 8, B and C, and fig. S7E). In combination, these 
data establish that in vivo PD-1 engagement impairs cytoskeletal rearrangement in TILs and is critical for 
lytic function. 
 
Acute in vitro blockade of PD-1 does not restore killing and cytoskeletal polarization 
To further understand the role of PD-1, we investigated the effects of acute PD-1 blockade given only 
during in vitro killing and imaging assays. When HA-specific Clone 4 TILs or CTLs were treated with the 
same antibody against PD-1 as used in vivo, or when RencaHA-PD-L1-/- target cells were used target cell 
killing was not enhanced (Fig. 9A). Similarly, the lytic activity of HA-specific TILs or CTLs was not inhibited 
by RencaHA target cells that overexpress PD-L1 (Fig. 9A, and fig. S6D). These data indicate that PD-1 did 
not acutely regulate cytolysis by TILs and CTLs in vitro.  
 
When we investigated the effect of acute PD-1 blockade on F-actin distribution and Ca2+ influx in HA-
specific CTLs and TILs, we found that it did not enhance these critical elements of cellular polarization (Fig. 
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9, B to D, and fig. S8). On the contrary, acute treatment with antibody against PD-1 increased the 
percentage of Clone 4 CTL and TIL cell couples with Renca+HA target cells that translocated from its initial 
target cell binding site by at least one interface diameter increased from 4±2% of CTLs to 24±7% and from 
14±3% of TILs to 50±9% (Fig. 9B). However, acute PD-1 blockade did not affect F-actin central clearing (Fig. 
9C) nor enrichment in the 10% of the cell volume with the highest F-tractin amounts (fig. S8C). Acute PD-
1 blockade also didn’t enhance Clone 4 CTL calcium signaling, but slightly impaired it around the time of 
tight cell coupling (Fig. 9D). While PD-1 blockade in vivo thus restored a substantial fraction of the 
impaired cell couple maintenance of TILs acute in vitro blockade could not do so. On the contrary, PD-1 
blockade impaired some elements of CTL signaling and cell polarity consistent with in vitro  data in a model 




The mechanisms underpinning the defective killing ability of TILs are still uncertain. A number of 
alterations in TIL activation have been described, including reduced actin polymerization (43-45), reduced 
calcium signaling among other proximal defects (24, 46, 47), increased expression of the inhibitory 
signaling mediators SHP-1 and Cish (46, 48) and decreased functional avidity of the T cell receptor (49). In 
human TILs activated by super-antigen-incubated B cell lines MTOC recruitment to the cellular interface 
and F-actin clearance from its center were impaired in a Galectin-3-dependent fashion (50). Metabolic 
defects in the glucose-poor tumor microenvironment are likely as enhancement of TIL glycolysis leads to 
improved tumor killing (51, 52). By establishing an experimental system for the rapid ex vivo imaging of 
the antigen-driven interaction of TILs with their tumor target cells we further describe the cellular 
mechanism of tumor immune suppression: Prolonged PD-1 signaling in vivo impaired Ca2+-sensitive 
cytoskeletal polarization and diminished TIL lytic activity. We could recapitulate key features of TIL 
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suppression using the interaction of only CTLs and tumor cell spheroids. Time is a critical element of this 
mechanism as, first, the polarization defect affected cell couple maintenance more than cell couple 
formation and, second, PD-1 blockade was only effective over days within the tumor microenvironment, 
but not acutely.  
 
Whereas TILs and SILs form cell couples with their tumor target cells, often within seconds of cell coupling 
TILs and SILs increasingly developed lamellae pointing away from the target cell interface. Recruitment of 
the Arp2/3 complex to the interface periphery, the principal means by which T cells to generate F-actin 
(53), was similar between TILs and CTLs. In contrast, recruitment of cofilin and Coronin 1A, key negative 
regulators of F-actin, was enhanced in TILs. This is expected to slow actin turnover by inhibition of the 
Arp2/3 complex by Coronin 1A and destabilization of F-actin filaments by cofilin. Slowed F-actin turnover 
is consistent with the decreased ability of TILs to move F-actin to interface edge while clearing the center 
which is considered to be critical for effective killing (36). Four elements of tumor immune suppression 
have already been linked to cofilin. The prostaglandin PGE2 is an established element of Clone 4 tumor 
immunosuppression (54) and inhibits actin polymerization in phagocytosis through activation of cofilin 
(55). Similarly, adenosine receptors that in the tumor microenvironment mediate immune suppression by 
adenosine (6, 7) inhibit cofilin inactivation in cardiomyocytes (56). Cofilin activation can also be inhibited 
by oxidation in T cells and mesenchymal cell motility (57, 58). The low oxygen environment of solid tumors 
(59) thus is consistent with enhanced cofilin activity. Finally, low levels of intracellular ATP induce cofilin 
activation by Chronophin in neurons (60), a process that is equally conceivable in the energy-starved 
tumor microenvironment. Consistent with our suggestion that Coronin 1A impairs F-actin dynamics in 
TILs, localized Coronin 1A inhibition in CD4+ T cells allows the efficient formation of a signaling-enhancing 




We observed that diminished in vivo PD-1 engagement could partially restore the ability of TILs to 
maintain a polarized cell couple with the tumor target cells and kill. In contrast, acute blockade of PD-1 
during its in vitro interaction with Renca tumor target cells did not rescue impaired TIL polarization nor 
killing. These data suggest that extended in vivo engagement of PD-1 induces a ‘polarization-impaired 
state’ that requires hours to days to form and revert. In support, 24h co-culture of primary T cells with 
various tumor cell types diminishes the ability of the T cells to form cell couples with allogeneic antigen-
pulsed B cells (44) is partially controlled by PD-1 (43).  Similarly, in a model of persistent LCMV infection T 
cell mobility, an indicator of polarization, was impaired in a PD-1-dependent fashion (17). With time, T 
cells can switch between suppressed and active states. In vitro culture of TILs in IL-2 for more than 6h can 
overcome diminished TIL killing of tumor target cells (61) and in vitro resting of TILs for >24h restores 
impaired tetramer binding to the TCR (49). In the LCMV model restoration of T cell motility in vivo became 
apparent after 1h of anti-PD-1 treatment and increased over the next 16h (17). PD-1 could also exert 
indirect effects within the tumor microenvironment through enhanced lineage stability of FoxP3+ Tregs 
(62) and suppression of IFNg-dependent innate and adaptive immunity (63). In addition, engagement of 
the costimulatory receptor CD28 is required for the restoration of T cell function by PD-1 blockade in vivo 
(64, 65). While HA-specific Clone 4 TILs may have access to the CD28 ligands CD80 and CD86 on the surface 
of tumor infiltrating professional antigen presenting cells, there is no such access during the in vitro 
interaction of Clone 4 T cells with Renca+HA target cells. At this time, it is still unresolved as to which is 
more important in the establishment of the TIL polarization-impaired state, the extended time of PD-1 
engagement or indirect effects of PD-1 within the tumor. The need for extended PD-1 engagement within 
the context of the tumor microenvironment makes it difficult to link established signaling roles of PD-1, 
that are largely investigated acutely and in vitro, to the in vivo inhibition of TIL polarization and function 
by PD-1. Nevertheless, transcriptional changes in TILs are conceivable, as sustained engagement of 
another receptor, the TCR by antigen, can substantially alter the transcriptional program of T cells (66) as 
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also shown in the context of cancer (67). In this context, differential expression of cytoskeletal 
components as determined here may contribute to the TIL polarization defect even though their PD-1 
dependence still needs to be determined. Metabolic changes are also conceivable, as enhanced tumor 
killing by blockade of PD-1 is associated with increased glycolysis (52). Future investigations of the 
mechanisms of PD-1 function will have to take into account the difference between sustained in vivo and 
acute in vitro roles observed here. 
 
 
Materials and Methods 
Cells and Media 
‘Complete medium’ consisted of RPMI-1640 plus L-glutamine (Gibco) supplemented with 10% FBS 
(Hyclone defined, US source, GE healthcare), 50µM β-Mercaptoethanol (Gibco), and PenStrep (Gibco) at 
100U/mL penicillin and 100µg/mL streptomycin. RencaWT cells were maintained in complete medium. 
RencaHA cells were maintained in complete medium supplemented with 100ug/ml geneticin. Clone 4 T 
cells were maintained in complete medium supplemented with 50U/mL rh-IL-2 (NIH/NCI BRB preclinical 
repository)(‘IL-2 medium’). Phoenix cells were maintained in DMEM with 4.5g/L D-glucose, L-glutamine 
and sodium pyruvate (Gibco) supplemented with 10% FBS (Hyclone define, US source, GE healthcare), 
MEM non-essential amino acids (Gibco), PenStrep (Gibco), 300µg/mL Hygromycin (Invitrogen) and 
1µg/mL Diphtheria toxin (Sigma). 
 
Mice 
Clone 4 TCR transgenic mice (RRID: IMSR_JAX:005307) were bred and maintained at the University of 
Bristol under specific pathogen free conditions. All Clone 4 mice were culled for experimental use between 
6 and 12 weeks of age. BALB/c mice were purchased from Charles River Laboratories at six weeks of age 
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and then maintained at the University of Bristol under specific pathogen free conditions. All mice were 
culled using schedule one methods and any experimental procedures were conducted in accordance with 
protocols approved by the UK Home Office. 
 
Clone 4 CD8+ T cell isolation, stimulation, and retroviral transduction 
Procedures used for the isolation and stimulation of TCR transgenic T cells have been extensively detailed 
elsewhere (29, 68, 69). Briefly, red blood cells were removed from dissociated spleens using ACK lysis 
buffer (Gibco) and splenocytes were plated at 5x106 cells per well, in 1 mL of complete medium, in a 24-
well plate. KdHA peptide (IYSTVASSL) was added to a final concentration of 1µg/mL and cells were 
incubated overnight. Primed cultures were washed five times in PBS to remove unbound peptide and then 
retrovirally transduced as extensively detailed elsewhere (29, 68, 69). Briefly, cells were resuspended in 2 
mL retrovirus-enriched supernatant from transfected Phoenix-E cells. Protamine sulphate was added to a 
final concentration of 8µg/mL. Plates were centrifuged for 2 hours at 200xg, at 32oC. Following 
transduction, cells were re-plated at 4x106 cells per well, in 2 mL IL-2 medium, in a 24-well plate. Cells 
were cultured for a further two days. CTLs were sorted and imaged, or adoptively transferred into 
RencaHA tumor bearing mice, on day four.   
 
RencaHA tumor growth in BALB/c mice and adoptive transfer of Clone 4 CD8+ T cells 
To induce tumor growth, female 6-8-week old BALB/c mice were injected subcutaneously in the scruff of 
the neck with 1x106 RencaHA cells suspended in PBS. Mice were monitored regularly to assess tumor 
growth. Tumor size was measured using callipers and calculated using the equation: volume (V)=L2xW/2, 
where length (L) is the longest measurement and width (W) is measured perpendicularly to length. Mice 
were culled if tumor volume exceeded 15mm in any one direction or any humane end points were 
reached. GFP-positive Clone 4 CTLs were resuspended in PBS at 2x107 cells per mL, and 200µL injected 
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into the tail vein of a tumor bearing mouse. Unless otherwise specified, only mice bearing tumors over 
500µm3 were used and tumors were harvested 96 hours after transfer.  
 
In vivo anti-PD-1 immunotherapy 
Mice received three doses of either anti-PD-1 (RMP1-14, Bio X cell, RRID: AB_10949053) or rat IgG2a 
isotype control (2A3, Bio X cell, RRID: AB_1107769) monoclonal antibodies on days one, three and five of 
treatment by tail vein injection. Each dose consisted of 250µg mAb in 200µL PBS.  CTL adoptive transfer 
occurred on day two and mice were culled on day six. Tumor measurements were taken on day one and 
six, prior to culling.  
 
Isolation of TILs 
Tumors were collected into 3.2mL RPMI-1640, roughly chopped with sterile scissors, and tumor cell 
dissociation enzymes (Miltenyi Biotec) were added as per manufacturer’s instructions. Tumors were 
incubated at 37oC for 45 minutes, and briefly vortexed every 10 minutes to enhance dissociation. The 
tumor suspension was then passed through a 40µm sieve, and red blood cells removed using ACK lysis 
buffer. Cells were resuspended in 600µL MACs buffer (PBS , 2mM EDTA, 0.5% BSA) with 65µL MACs 
microbeads (Miltenyi) and incubated at room temperature for 30 minutes. CD8a (Ly-2) microbeads were 
used to enrich for CD8+ T cells; CD45 microbeads were used to enrich for all lymphocytes. Positive 
selection of the magnetically labelled cell populations was performed using MACS LS-columns (Miltenyi 
Biotec). Collected cells were resuspended in 500µL imaging buffer for immediate sorting, or 500µL FACS 
buffer for antibody staining. 
 
Generation of SILs 
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RencaWT mCherry were resuspended at a concentration of 1x105 cells/ml, mixed with Matrigel (Corning) 
at 4°C, seeded in a 24 well plate at a final concentration of 500 cells/blob, and left to solidify for 10 minutes 
at 37°C. 2 ml of cell medium were added to each well and incubated at 37°C for 11 days. On the 11th day, 
each blob was washed twice in PBS and incubated for 30 minutes with 1 ml of Cell Recovery Solution 
(Corning). Spheroids were collected in a 15 ml Falcon tube and pulsed with KdHA peptide at a final 
concentration of 2µg/mL for 1 hour. Pulsed spheroids were re-embedded in Matrigel together with 5x105 
primed Clone 4 CTLs per blob. The following day, blobs were washed twice in PBS and incubated with 1 
ml of Cell Recovery Solution (Corning). Spheroids were collected, washed through a 70 µm sieve and then 
disaggregated to retrieve SILs in 500µL imaging buffer for immediate FACS sorting. 
 
Imaging of Clone 4 CTLs, TILs and SILs 
After retroviral transduction or TIL/SIL extraction, T cell cultures were sorted to isolate GFP-positive T cells 
and resuspended in ‘imaging buffer’ (10% FBS in PBS with 1mM CaCl2 and 0.5mM MgCl2). As target cells, 
1x106 RencaWT cells were pulsed with KdHA peptide at a final concentration of 2µg/mL for 1 hour 
(Renca+HA) cells. Imaging was done in glass bottomed, 384-well optical imaging plates (Brooks life science 
systems) at 37oC using a Perkin Elmer UltraVIEW ERS 6FE confocal system attached to a Leica DM I6000 
inverted epifluorescence microscope and a Yokogawa CSU22 spinning disk. A 40x oil-immersion lens 
(NA=1.25) was used for all imaging experiments, unless otherwise stated. Every 20 seconds for 15 minutes 
a z-stack of 21 GFP images (1µm z-spacing) was acquired, as well as a single, mid-plane differential 
interference contrast (DIC) image.  
 
Some imaging experiments involved prior treatment of T cells with 40nM Jasplakinolide, 10µg/mL anti-
PD-1 mAb (RMP1-14, Bio X cell, RRID: AB_10949053) or 5mM NiCl2 plus 20µM BAPTA-AM (Molecular 
Probes). In all cases, reagent was added at the desired concentration for 30min prior to imaging, and cells 
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were incubated at 37oC/30oC for BAPTA-AM. Reagents with the exception of BAPTA-AM were also present 
throughout imaging.  
 
For imaging the elevation of the cytoplasmic calcium concentration, Clone 4 T cells were incubated with 
2 µM Fura-2 AM (Molecular Probes) for 30min at room temperature in imaging buffer and washed twice 
thereafter. Because of limiting cell numbers such washing was not feasible for Clone 4 TILs. Clone 4 T cells 
were activated with Renca+HA APCs as described above and every 10s for 15min, one bright field image, 
one fluorescence image with excitation at 340nm and one fluorescence image with excitation at 380nm 
were acquired, at 37oC using a 40x oil objective (NA=1.25) on a Leica DM IRBE-based wide filed system 
equipped with Sutter DG5 illumination and a Photometrics Coolsnap HQ2 camera. For analysis, field-
averaged background fluorescence was subtracted from the fluorescence data and the ratio of the Fura-
2 images upon excitation at 340nm versus 380nm was calculated and multiplied by 100 to fit into the 8-
bit display scale. Average ratio within a circular region of interest of the dimensions of the T cell was 
determined over time for each T cell.    
 
Analysis of live cell imaging data  
Image analysis protocols have previously been described (29, 68, 69). Using Metamorph image analysis 
software (Molecular Devices), CTLs forming conjugates with Renca target cells were identified using the 
DIC reference images. Tight cell couple formation was defined as the first time point at which a maximally 
spread immune synapse forms, or two frames following initial cell contact, whichever occurred first. To 
assess CTL and TIL morphology, every DIC frame following tight cell couple formation was assessed for the 
presence of off-synapse lamella, defined as a transient membrane protrusion pointing away from the 
immune synapse, followed by retraction. For each cell couple, the initial position of the immune synapse 
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on the Renca+HA target cell was compared to the position in the final frame. If the T cell had migrated by 
more than the immune synapse diameter, this was classed as translocation.  
 
To analyse protein spatiotemporal distribution, we used an improved version of the method described in 
(30) as implemented in version 2.8 of the open source CellOrganizer software (http://CellOrganizer.org) 
(68, 70, 71). There were two improvements.  Synapse tracking.  The previous method required annotation 
of the cell couple synapse position for each time point, while the modified method requires only 
annotation at the initial time point. The fluorescence image for the initial frame is segmented by 
thresholding via Otsu’s method (72), and an ellipse is fitted to the segmented object containing the 
manually annotated synapse position (the T cell).  A window of 61 by 61 around the synapse position is 
chosen, and a circle containing the APC is found via Hough transform of the DIC image (73). The 
coordinates of the endpoints of the synapse are found as the intersection points of the T cell ellipse and 
the APC circle. This process is repeated for preceding or subsequent frames with the T cell location 
information in the previous frame used to find the T cell in the current frame. The coordinates of the two 
synapse endpoints are saved across time. Alignment refinement. To correct for inadvertent rotation 
during the initial alignment of all the cells within the population to be analyzed, we implemented two 
improvements. The first step is to infer a rotation angle around the z-axis via a regression model using as 
features the intensities of evenly-distributed coordinates in the cylinder originating from the synapse 
center. The second step is to decide whether to flip the cell by 180 degrees around the y-axis using a 
binary classifier with the total intensity of the first and second half of all slices as features. The regressor 
and classifier were trained with images that had been manually annotated. Finally, we fit a line through 
the synapse region in the central slice and perform a fine correction of the rotation around the z-axis using 




As a first measurement of protein enrichment we defined the 10% of the cell volume with the highest 
fluorescence intensity across the average of the entire population of cells analyzed and determined 
enrichment in this volume relative to the entire cell, as established (30). Additional regions of interest 
were defined using geometrical criteria. As the synapse region in Cofilin-GFP expressing T cells we used a 
cylinder normal to and one voxel distant from the synapse plane, with its axis centered on the synapse 
region, a radius of 8 voxels, and a height of 4 voxels. As the region defining the interface center in F-
tractin-GFP-expressing cells we a cylinder similar to the one in the Cofilin analysis but with a radius of 8/3 
voxels. The computational analysis of Cofilin-GFP distributions required additional adaptations as Cofilin-
GFP accumulated prominently in the nucleus. Enrichment in the 10% of the cell volume with the highest 
fluorescence intensity did not reliably reflect interface enrichment. As the T cell nucleus often closely 
approaches the cellular interface, a cylindrical interface measurement region captured more of the 
interface accumulation but still not exclusively so. Therefore, we also sorted time points into those with 
(>135% fluorescence intensity in regions of interface accumulation above cellular background) and 
without accumulation, computationally determined enrichment in the 10% of the cell volume with the 
highest fluorescence intensity at only the time points with accumulation and multiplied the enrichment 
intensity by the fraction of cell couples with Cofilin accumulation. 
 
Determination of F-actin amounts by Phalloidin staining 
T cells were stained with Phalloidin Alexa488 as previously described (41) and cover slips were imaged as 
three-dimensional image stacks on a Leica TCS SP8 AOBS laser scanning microscope using a 40x oil NA=1.3 
objective. Using ImageJ, z-stacks of phalloidin-stained T-cells were maximum-projected and these images 
were then 2D median filtered using a filter radius of 1, enabling noise reduction and edge-preservation. 
Otsu global thresholding (72) was used to binarize the images. As this algorithm systematically 
overestimated the threshold each threshold value was multiplied by 0.2 to provide a consistent offset.  
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Objects were detected as regions of contiguous foreground pixels (8-way connectivity); as such holes were 
filled and a watershed algorithm used to split merged objects. Cell areas and mean fluorescent intensities 
were measured and cell areas were converted to volumes assuming spherical geometry. 
 
T cell killing assays 
Renca+HA or RencaWT cells were stained with 10µM cell trace violet (CTV) and plated at a density of 1x104 
cells per well of a 384-well plate (Perkin Elmer) in 100µL complete medium. Cells were incubated at 37oC 
for a minimum of five hours to allow adherence and spreading. Prior to imaging, medium was exchanged 
for 50µL/well imaging buffer. Clone 4 CTLs, TILs or SILs were resuspended in imaging buffer at a density 
of 2x105 cells/mL. The imaging plate was then mounted on a Leica DMI6000 inverted epifluorescence 
widefield microscope, at 37oC, with a humidified CO2 enrichment attachment, a motorized stage, and 
adaptive focus control enabled by image analysis software (Leica LAS-X). CTV stained Renca cells were 
imaged and the positions for 2-3 fields of view were saved per well. 50µL of the T cell culture (giving a 
total of 1x104 cells/well) were added per well. Images of CTV-stained Renca cells were acquired every 30 
minutes for 10 hours, using adaptive focus control to prevent drift. Using Metamorph image analysis 
software, a mask was generated using thresholding for light objects and adjusted to match the fluorescent 
signal. The same thresholding criteria were then used for all conditions within that experiment. The area 
of the field covered by CTV-stained Renca+HA cells was measured, the average percentage change in cell 
area was calculated for each time point, and a gradient describing the rate of cell area change was 
calculated. This was corrected for a control condition, in which no T cells were added, providing a 
normalized value for the rate of cell area change across all experiments.  
 
Generation of RencaHA-PD-L1-/- and PD-L1-GFP over expressing cell lines  
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Methods used closely follow those described in (74). SgRNAs were designed using three programmes: 
Benchling, Broad institute, and MIT CRISPR design. The six top common hits were selected. DNA 
oligonucleotides encoding these sgRNAs were inserted into the pSpCas9(BB)-2A-GFP vector (Addgene). 
Vectors were transfected into RencaHA cells using Lipofectamine 2000 as per manufacturer’s instructions. 
After 24 hours, FACS was used to separate single GFP-positive cells into wells of a 96-well plate. Colonies 
were expanded and screened for PD-L1 loss by flow cytometry. Several clones were further screened to 
compare MHC class I expression, HA expression and in vitro proliferative ability to the original RencaHA 
cell line, and the most similar clone (B10) was selected.  
 
pSpCas9PDL1 b F  CACCGTCCAAAGGACTTGTACGTGG 
pSpCas9PDL1 b R AAACCCACGTACAAGTCCTTTGGAC 
Primers encoding gRNA sequences for CRISPR/Cas9 mediated knockout of PD-L1.  
 
The cDNA encoding PD-L1 was cloned into a pSRαGFP vector to create a PD-L1-GFP fusion construct. This 
vector was transfected into RencaWT cells using lipofectamine 2000 (Invitrogen) and selected with 
200µg/mL geneticin. Cells were FACS-sorted for GFP-positive cells, and analyzed by anti-PD-L1 antibody 
staining and flow cytometry to assess over expression and localization of GFP-conjugated PD-L1. 
 
Phos-tag western blotting to assess cofilin phosphorylation 
Round-bottom, 96-well plates were coated overnight with 10µg/mL anti-CD3 antibody (145-2C11, 
BioLegend, RRID: AB_2632707) in PBS at 4oC. Clone 4 CTLs or TILs were resuspended in complete medium 
at a concentration of 1.5x106 cells/mL and incubated at 37oC. 100µL of CTLs or TILs was added to the well, 
along with 100µL of complete medium. Cells were centrifuged in the plate for 30 seconds at 250xg to 
ensure uniform contact with the anti-CD3 coated plastic. The plate was placed immediately at 37oC for 1, 
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2, or 5 minutes. After incubation, cells were lysed with 100µL ice-cold RIPA buffer. Phos-tag reagent 
(Wako) was added to 15% SDS-PAGE gels, as per manufacturers protocols. Standard ECL protocols were 
used for immunodetection. Antibodies used were anti-cofilin (D3F9, Cell Signaling, RRID: AB_10622000), 
anti-GAPDH (14C10, Cell Signaling, RRID: AB_10693448) and anti-IgG-HRP (Cell Signaling).  
 
Analysis of surface receptor staining by flow cytometry 
Cells to be fixed were stained with Zombie live/dead fixable exclusion dyes (BioLegend). Cells were 
incubated with Fc receptor blocking antibody (anti-CD16/CD32, clone 93, eBioscience). Surface staining 
was conducted in PBS + 0.5% FBS. Cells were fixed with 4% PFA using standard protocols. Antibodies used 
for cell surface staining included: anti-CD279/PD-1 BV785 (29F.1A12, Biolegend, RRID: AB_2563680); anti-
CD274/PD-L1 BV421 (MIH5, BD Bioscience, cat no 564714); anti-CD90.1/Thy1.1 PerCP Cy5.5 (OX-7, 
Biolegend, RRID: AB_961437); anti-Vb8.1/Vb8.2 TCR FITC (KJ16-133, eBioscience, RRID: AB_465261). SIL 
PD-1 expression was normalized to that of CTLs. 
 
In vivo killing assay 
BALB/c mice were injected with 4x106 primed Clone 4 CTLs, or PBS alone, by tail vein injection. On the 
second day after adoptive transfer, BALB/c splenocytes were pulsed with or without KdHA peptide at a 
final concentration of 2µg/mL for 1 hour, then washed and resuspended in PBS. KdHA pulsed splenocytes 
were then stained with 5µM CellTrace violet (CTV) (high), whilst un-pulsed splenocytes were stained with 
0.5µM CTV (low). Splenocytes were washed and resuspended in PBS. Immediately prior to injection, high 
and low stained splenocytes were mixed in equal numbers, and 5x106 cells were injected into BALB/c 
mice. After 24 hours, splenocytes were analyzed by flow cytometry and gated on live/dead dye exclusion 





Data were checked for conformity to the Normal Distribution using the SAS procedure UNIVARIATE 
including the Anderson-Darling and Shapiro-Wilk tests and graphical methods. To achieve conformity to 
the Normal Distribution subcellular distribution enrichment ratios had to be transformed to logarithms. 
Data from independent experiments were pooled if the 95% confidence intervals of the independent 
experiments overlapped. To confirm validity of such pooling of data from independent experiments, 
sources of variation were analysed in more detail in three representative data sets (fig. S9).  Specifically, 
our analysis asked how significant differences are between experimental repeats within a treatment, such 
as CTL experimental repeat 1 versus 2 versus however many repeats there are, as opposed to differences 
between treatments, CTLs versus TILs. First, each data set was tested for auto-correlation between 
repeated measurements on the same cell. First-order auto-correlation (P<0.05) was detected in all sets of 
repeated measurements by the Durbin-Watson statistic (SAS procedure AUTOREG). Accordingly, further 
analysis was conducted by the method of General Linear Models with an AR(1) covariance matrix in SAS 
procedure MIXED using REML estimation. The results showed that, while the difference between 
treatments was always significant, experiments within treatments did not differ significantly. The p values 
for these differences in the three representative experiments are: 
      Treatment  Experimental repeats 
Time until first off interface lamella (Fig. 2G) p=0.0035  p=0.06   
Cofilin enrichment (fig. S4B)   p=0.0015  p=0.67 
Calcium signalling (Fig. 5D)   p<0.0001  p=0.99 
 




Differences between experimental conditions were then analysed at individual time-points. The 
Bonferroni correction for multiple comparisons was applied so that, for example across 11 time points 
analysed, only differences with p<0.0045 were considered to be significant and are reported as such.  
Applying this stringent correction increases the rate of false negatives. Our quantification of protein 
distributions, however, involved repeated measurements that are not necessarily independent, so the 
over-conservatism of the Bonferroni adjustment provides a compensatory safeguard.  Imaging data 
grouped over time ranges were not affected by this problem. The frequency of occurrence of off-synapse 
lamellae or cellular translocation was analysed using the z transformation for proportions. All other data 
types were analysed by Student’s t tests, unpaired, unpaired with Welch’s correction for unequal variance, 
multiple t-tests with two-stage set-up method of Benjamini, Krieger and Yekutielli, ANOVA or by non-
parametric tests, Mann Whitney u-tests or Kruskall-Wallis test, as appropriate and indicated in the Figure 
captions. In few cases where it was difficult to satisfy all assumptions for the statistical tests under 
consideration, p values were calculated using the most appropriate tests and the test resulting in the 
highest p value is reported as the most conservative approach. Standard tests were executed with 





Fig. S1. Clone 4 CTLs efficiently kill RencaHA cells in vivo 
Fig. S2. Diminished MTOC polarization of Clone 4 TILs towards the T cell-APC interface 
Fig. S3. F-actin distribution is impaired in TILs 
Fig. S4. Greater enrichment of cofilin, Coronin 1A, and Chronophin in TILs than CTLs 
Fig. S5.  Increased cofilin phosphorylation, but reduced cofilin expression in TILs 
Fig. S6. Characterization of RencaHA PD-L1-/- and RencaHA PD-L1-GFP tumors 
Fig. S7. Loss of PD-1 engagement in vivo rescues cytoskeletal polarization 
Fig. S8.  Acute in vitro blockade of PD-1 does not restore cytoskeletal polarization 
Fig. S9. Data pooling 
Movie S1. Interactions of a tubulin-GFP transduced Clone 4 CTL and TIL with Renca+HA target cells.  
Movie S2. Interactions of a F-tractin-GFP transduced Clone 4 CTL, TIL, and CTL in the presence of 
Jasplakinolide with Renca+HA target cells. 
Movie S3. Interactions of a cofilin-GFP transduced Clone 4 CTL and TIL with Renca+HA target cells. 
Movie S4. Interaction of a Coronin 1A-GFP transduced Clone 4 CTL with a Renca+HA target cell. 
Movie S5. Interactions of an Arp3-GFP transduced Clone 4 CTL and TIL with Renca+HA target cells. 
Movie S6. Interaction of a Chronophin-GFP transduced Clone 4 CTL with a Renca+HA target cell. 
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Fig. 1. Tumour exposure impairs CD8+ T cell killing ability. (A)  Experimental schematic for in vitro imaging 
the interaction of HA-peptide pulsed Renca tumor cells (Renca+HA) with retrovirally transduced, HA-
specific in vitro activated CTLs in comparison to the same cells after adoptive  transfer into mice with 
established Renca+HA cells tumors or co-culture with RencaHA spheroids. (B to D) Fluorescence microscopy 
analysis of CTV-labelled Renca or Renca+HA  cell in vitro killing by Clone 4 CTLs or TILs. Images (B) are 
representative of 13 experiments. The percentage area change (C) are means ±  SEM from a minimum of 
3 fields of view/time point and are representative of 7 experiments. Average Renca+HA cell death rate data 
(D) are means ± 95% confidence interval from 7 independent experiments. Scale bar, 100µm. ****P< 
0.0001 by Student’s t test with Welch’s correction.  
 
Fig. 2. TILs have delayed MTOC polarization and diminished cell couple stability. (A to C) Microscopy 
analysis of tubulin-GFP transduced HA-specific CTLs and TILs interacting with Renca+HA cells over time. DIC 
(upper) and false-colored fluorescence intensity (lower) images (A and B) are representative of at least 3 
experiments. The percentage of MTOC localized at the immune synapse (C) are means ± SEM of 51 CTLs 
and 55 TILs from all experiments. (D to H) Microscopy analysis of HA-specific CTLs and TILs interacting 
with Renca+HA cells over time. DIC images (D and E) with the original position of tight-cell couple formation 
with Renca+HA cells (yellow line) and off-synapse lamellae (red arrow) are representative of at least 6 
independent experiments. The percentage of cells with off-synapse lamellae (F), time of first off-synapse 
lamella (G), and translocating away from the contact site (H) are means ± 95% confidence interval of 138 
CTLs and 137 TILs from all experiments. Scale bars, 5µm. *P< 0.05, ** P< 0.01 (G), ** P< 0.0036 (C, to 





Fig. 3. Impaired interface F-actin distributions are associated with poor TIL killing ability. (A to E) 
Microscopy analysis of F-tractin-GFP transduced Clone 4 CTLs, with and without Jasplakinolide, and TILs 
interacting with Renca+HA cells over time. DIC (upper) and false-colored fluorescence intensity (lower) 
images (A to C) are representative of at least 3 experiments. Computational analysis of GFP fluorescence 
distribution (D and E) is displayed  in horizontal slices perpendicular to the synapse averaged over all cells 
and time points with the location of the central cylinder (D) and the 10% of the cell volume with the most 
intense F-actin accumulation (E) highlighted in yellow. Quantification of F-actin enrichment in TIL and CTL 
(D) or TIL and CTL treated with and without Jasplakinolide (Jasp) (E) in the highlighted volumes are means 
± SEM of 60 CTLs, 51 TILs, or 40 CTLs+Jasp from at least 3 separate experiments. (F) Fluorescence 
microscopy analysis of in vitro killing of Renca+HA cells by HA-specific CTLs treated with or without Jasp and 
TILs.  Average Renca+HA cell death rate data are means ± SEM from at least 4 independent experiments. 
Scale bars, 5µm. ** P< 0.0045 (D, E, to account for Bonferroni correction), ***P< 0.001, and ****P< 
0.0001 by Student’s t-test (D), 1-way ANOVA (E) or pair-wise Student’s t-test with Welch’s correction (F). 
 
Fig. 4. Cofilin and Coronin, but not Arp2/3, are more extensively enriched at the cell contact interface 
in TILs. (A to G) Microscopy analysis of Cofilin-GFP (A) or Arp3-GFP (B) transduced HA-specific CTLs and 
TILs interacting with Renca+HA cells over time. DIC (upper) and false-colored fluorescence intensity (lower) 
images are representative of  at least 2 independent experiments. Computational analysis of GFP 
fluorescence distribution is displayed in horizontal slices perpendicular to the synapse (C) averaged over 
all cells and time points with the interface region cylinder (cofilin) and the 10% of the cell volume with the 
most intense Arp3 accumulation highlighted. Quantification of interface GFP enrichment at individual 
time points (D and E) and early (F) and late (G) times in the highlighted volumes are means ± 95% 
confidence interval of 90 CTLs and 58 TILs (D) or 56 CTLs and 51 TILs (E ) from all experiments with addition 
of Coronin 1A data (fig. S4, D to G) in (F) and (G) . (H and I) Western blot for pCofilin in lysates of HA-
 
 37 
specific CTLs and TILs after activation with antibodies against CD3 for the times indicated. Blots (H) are 
representative of at least 3 independent experiments (see also fig. S5A). The percentage of pCofilin (I) are 
means ± 95% confidence interval from all experiments. Scale bars, 5µm. *P< 0.05, **P< 0.01, and ****P< 
0.0001 by Student’s t-test (D to G) or two-way ANOVA (I). 
 
Fig. 5. TILs display a reduced cytoplasmic calcium influx. (A to D) Microscopy analysis of Fura-2-loaded 
Clone 4 CTLs and TILs interacting with Renca+HA cells over time. DIC (upper) and false-colored fluorescence 
images (A and B) are representative of at least 2 experiments. (C, D) Ratio of Fura-2 emission upon 
excitation with 340nm over 380nm data are (C) five randomly chosen single CTLs and TILs or (D) mean ± 
SEM from 50 CTLs, 14 TILs from ³2 independent experiments. (E) Fluorescence microscopy analysis of 
Renca+HA cell in vitro killing by HA-specific CTLs treated with NiCl2 and BAPTA-AM, as indicated.  Average 
Renca+HA cell death rate data are means ± SEM from 3 independent experiments. (F and G) Microscopy 
analysis of HA-specific CTLs treated with and without NiCl2 and BAPTA-AM interacting with Renca+HA cells 
over time. The cell coupling frequencies (F) are means ± 95% confidence interval of at least 3 independent 
experiments. The percentage of Clone 4 CTLs with off-synapse lamellae (G, left), time of first off-synapse 
lamella (G, middle), and translocating away from the initial contact site (G, right) are means ± 95% 
confidence interval of 138 CTLs (from Fig. 2, F to H) and 31 CTLs after treatment from 3 independent 
experiments. (H) Graphic summary of TIL defects. Cell shapes, cytoplasmic calcium concentrations, and 
the distributions of lytic vesicles, cytoskeletal components and regulators of actin dynamics as listed on 
the bottom of the panels are given schematically for CTLs (left) and TILs (right) at 1-3min of tight cell 
coupling.  Scale bar, 5µm. **P< 0.01, and ****P< 0.0001 by Student’s t-test (D and F), Mann Whitney u-




Fig. 6. Co-culture of CTLs with Renca tumor cell spheroids induces a polarization-impaired state. (A) 
Two-photon microscopy analysis of the infiltration of Clone 4 CTLs into spheroids overnight. Image of 
mCherry-Renca cells (red) and calcein-labeled, HA-specific SILs (green) is representative of 3 experiments. 
(B) Fluorescence microscopy analysis of Renca+HA cell in vitro killing by HA-specific CTLs and SILs. Average 
Renca+HA cell death rate data are means ± SEM from 7 independent experiments. (C) Flow cytometric 
analysis of PD-1 expression on HA-specific CTLs and SILs. Data are normalized medians ± 95% confidence 
interval from 3 independent experiments. (D) Microscopy analysis of HA-specific CTLs and SILs interacting 
with Renca+HA cells over time. The percentage of cells with off-synapse lamellae (left), time of first off-
synapse lamella (middle) and translocating away from the contact site (right) data are means ± 95% 
confidence interval of 138 CTLs (from Fig. 2, F to H) and 43 SILs from 3 independent experiments. (E) 
Fluorescence microscopy analysis of Fura-2-loaded HA-specific CTLs and SILs interacting with HA peptide 
pulsed Renca+HA cells over time. Normalized Fura-2 emission data are means ± SEM from 50 CTLs (from 
Fig. 5D) and 40 SILs from 3 independent experiments. Scale bar, 100 µm. *P< 0.05, ***P< 0.001, and 
****P< 0.0001 by paired Student’s t-test (B), Student’s t-test with Welch’s correction (C), proportion’s z-
test (D, left and right), Mann Whitney u-test (D, middle) or Student’s t-test (E). 
 
Fig. 7. Loss of PD-1 engagement in vivo improves TIL killing ability. (A) Flow cytometric analysis of PD-1 
expression of naïve and primed Clone 4 CTLs, Clone 4 TILs and endogenous CD8+ TILs. Histograms are 
representative of at least 2 independent experiments. Data are means ± 95% confidence interval. (B and 
C) Analysis of subcutaneous RencaHA tumor growth in mice after treatment with antibody against PD-1 
and Clone 4 CTL adoptive transfer, as indicated (B). The percentage increase in tumour volume within 5 
days of 17 mice/condition with means ± 95% confidence interval are from 5 independent experiments. 
(D) Fluorescence microscopy analysis of Renca+HA cell in vitro killing by HA-specific TILs from untreated 
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control or mice treated with antibodies against PD-1. Average Renca+HA cell death rate data with means ± 
95% confidence interval are from 6 independent experiments.  
(E and F) Analysis of subcutaneous RencaHA and RencaHA PD-L1-/- tumor growth in mice after adoptive 
transfer of HA-specific CTL at the times indicated. Tumor volume (E) and survival (F) data of 7 RencaHA 
and 6 RencaHA PD-L1-/- tumour bearing mice are pooled from 2 independent experiments. *P< 0.05 and 
**P< 0.01 by one-way ANOVA (A), Mann Whitney u-test (C), paired Student’s t-test (D), or Mantel-Cox 
test (F). 
 
Fig. 8. Loss of PD-1 engagement in vivo partially rescues cytoskeletal polarization. (A) Fluorescence 
microscopy analysis of F-tractin-GFP transduced HA-specific CTLs and TILs from the indicated mice 
interacting with Renca+HA cells. Interface center F-actin accumulation data are means ± SEM of 60 CTLs, 
51 TILs (from Fig. 3D), 42 TILs from mice treated with antibody against PD-1, and 43 TILs from RencaHA 
PD-L1-/- tumors from 2 independent experiments. (B to D) Fluorescence microscopy analysis of Cofilin-GFP 
transduced HA-specific CTLs and TILs from the indicated mice interacting with HA peptide pulsed Renca+HA 
cells. Interface Cofilin-GFP accumulation data at individual time points (B) and  early (C) and late (D) times 
are means ± SEM (B) or means ± 95% confidence interval (C and D) of 90 CTLs, 58 TILs (from Fig. 4D), 32 
TILs from mice treated with antibody against PD-1, and 55 TILs from RencaHA PD-L1-/- tumors from at least 
2 independent experiments. *P< 0.05, **P< 0.01 (D), **P< 0.0045 (A, to account for Bonferroni correction) 
by one-way ANOVA. 
 
Fig. 9. Acute in vitro blockade of PD-1 does not restore killing and cytoskeletal polarization. (A) 
Fluorescence microscopy analysis of Renca+HA, Renca+HA PD-L1-/-, and Renca +HA PD-L1-GFP cell in vitro 
killing by HA-specific CTLs and TILs in the presence of antibody against PD-1, as indicated. Average 
Renca+HA cell death rate with means ± 95% confidence interval are from  at least 4 independent 
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experiments. (B) Microscopy analysis of HA-specific CTLs and TILs interacting with HA peptide pulsed 
Renca+HA cells in the presence of antibody against PD-1, as indicated. The percentage of cells translocating 
away from the contact site are means ± 95% confidence interval of 138 CTLs, 137 TILs (from Fig. 2, F to H), 
35 CTLs+anti-PD-1, and 24 TILs+anti-PD-1 from 2 independent experiments. (C) Fluorescence microscopy 
analysis of F-tractin-GFP transduced HA-specific CTLs and TILs interacting with HA peptide pulsed Renca+HA 
cells in the presence of antibody against PD-1, as indicated. Interface center F-tractin accumulation data 
are means ± SEM of 60 CTLs, 51 TILs (from Fig. 3D), 41 CTLs+anti-PD-1, and 28 C TILs+anti-PD-1 from 2 
independent experiments. (D) Fluorescence microscopy analysis of Fura-2-loaded HA-specific CTLs with 
Renca+HA cells in the presence of antibody against PD-1, as indicated. Normalized Fura-2 emission data are 
means ± SEM of 50 CTLs (from Fig. 5D) and 52 CTLs+anti-PD-1 from 2 independent experiments. *P< 0.05, 
**P< 0.0045 (to account for Bonferroni correction), ***P< 0.001, and ****P< 0.0001; by Kruskall-Wallis 
test with comparison to ‘Renca+HA’ (A, CTL), Kruskall-Wallis test and one-way ANOVA as it is difficult to 



































Fig. S1. Clone 4 CTLs efficiently kill RencaHA cells in vivo. Flow cytometry analysis of in vivo killing of HA-
pulsed (CTV high) and un-pulsed (CTV low) syngeneic splenocytes in BALB/c mice that did (right) or did 
not (left) receive Clone 4 CTLs 48h prior to labeled splenocyte injection. Histograms of live CTV+ cells are 






Fig. S2. Diminished MTOC polarization of Clone 4 TILs towards the T cell:APC interface. Fluorescence 
microscopy analysis of interactions between tubulin-GFP transduced Clone 4 CTLs or TILs and HA peptide-
pulsed Renca+HA cells over time. Position of MTOC relative to cell interface data are means ± SEM from at 
least 3 independent experiments (shown in Fig. 2C). T cells were divided into equal thirds (inset) and 
position was classed as part of regions 1, 2, 3 or 1.5 or 2.5 if the MTOC fell on a division line. ** P< 0.0036 






Fig. S3. F-actin distribution is impaired in TILs. (A) Computational analysis of F-tractin-GFP reporter 
fluorescence distributions in CTLs or TILs is displayed in horizontal slices perpendicular to the synapse 
averaged over all cells at the given time points from the imaging data in Fig 3, A and B. (B and C) 
Fluorescence microscopy analysis of the amount of F-actin in CTLs and TILs. Quantified phalloidin staining 






Fig. S4. Greater enrichment of Cofilin, Coronin 1A, and Chronophin in TILs. (A to C) Analysis of Cofilin-
GFP distribution in transduced Clone 4 CTLs and TILs interacting with HA peptide pulsed Renca+HA cells 
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over time. Images (A) were computationally generated from all of the fluorescence microscopy data in 
Fig. 4, C and D and are displayed with the location of the 10% of the cell volume with the most intense 
cofilin accumulation highlighted in yellow. Relative enrichment of intracellular Cofilin-GFP in the 
highlighted volumes (B) and accumulation in the interface cylinder (Fig. 4C) as adjusted for cells with 
accumulation above background (C) are means ± SEM from at least 3 experiments. (D to G) Microscopy 
analysis of Coronin1A-GFP transduced Clone 4 CTLs and TILs interacting with HA peptide pulsed Renca+HA 
cells over time. DIC (upper) and fluorescence (lower) microscopy images (D and E) are representative of 
at least 2 experiments. Computational analysis of GFP fluorescence distribution (F) is displayed  in 
horizontal slices perpendicular to the synapse averaged over all cells and time points with the location the 
10% of the cell volume with the most intense Coronin1A-GFP accumulation highlighted in yellow. 
Quantification of Coronin1A enrichment in CTL and TIL (G) in the highlighted volumes are means ± SEM of 
60 CTLs, 51 TILs, or 40 CTLs+Jasp from all experiments.  (H to K) Microscopy analysis of Chronophin-GFP 
transduced Clone 4 CTLs and TILs interacting with HA peptide pulsed Renca+HA cells over time. DIC (upper) 
and fluorescence (lower) microscopy images (H and I) are representative of at least 2 experiments. 
Computational analysis of GFP fluorescence distribution (J) is displayed  in horizontal slices perpendicular 
to the synapse averaged over all cells and time points with the location the 10% of the cell volume with 
the most intense Chronophin-GFP accumulation highlighted in yellow. Quantification of Chronophin 
enrichment in CTL and TIL (K) in the highlighted volumes are means ± SEM of 58 CTLs and 41 TILs from all 
experiments. Scale bars, 5µm. ** P< 0.0045 (to account for Bonferroni correction), ***P<0.001, and 






Fig. S5.  Increased cofilin phosphorylation, but reduced Cofilin expression in TILs. (A) Full-length western 
blot for pCofilin in lysates of Clone 4 CTLs and TILs activated with antibodies against CD3 for the indicated 
times. Blots are representative of 2 experiments in Fig. 4H. (B) Quantification of Western blot for Cofilin 
in lysates of HA-specific CTLs and TILs is means ± 95% confidence interval from 3 independent 





Fig. S6. Characterization of RencaHA PD-L1-/- and RencaHA PD-L1-GFP cell lines and tumors. (A) Flow 
cytometric analysis of the amount of PD-L1 on live RencaHA and RencaHA-PD-L1-/- cells. Dot plots are 
representative of 2 independent experiments. (B and C) Analysis of tumor growth (B) and survival (C) after 
subcutaneous inoculation of mice with RencaHA or RencaHA PD-L1-/- tumors, as indicated. Data from 14 
RencaHA and 10 RencaHA PD-L1-/- tumour bearing mice are pooled from 2 independent experiments. (D) 
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Flow cytometric analysis of the amount of PD-L1 and GFP on RencaWT and RencaWT-PD-L1-GFP cells. Dot 






Fig. S7. Loss of PD-1 engagement in vivo rescues cytoskeletal polarization. (A to C) Microscopy analysis 
of HA-specific CTLs and TILs from the indicated mice interacting with Renca+HA cells over time. The 
percentage of cells translocating more than one immune synapse diameter (A), with off-synapse lamellae 
(B) and time of first off-synapse lamella (C) are means ± 95% confidence interval of 138 CTLS, 137 TILs 
(from Fig. 2, F to H), 35 TILs from mice treated with antibody against PD-1, 28 TILs from RencaHA PD-L1-/- 
tumors from at least 2 independent experiments. (D) Analysis of relative enrichment of F-tractin-GFP in 
the 10% of the cell volume with the most intense F-tractin-GFP accumulation in F-tractin-GFP-transduced 
Clone 4 CTLs and TILs from the indicated mice after interacting with HA peptide pulsed Renca+HA cells. 
Data are means ± SEM from computational analysis of the microscopy data in Fig. 3E and Fig. 8A. (E) 
Analysis of relative enrichment of Cofilin-GFP in the 10% of the cell volume with the most intense Cofilin-
GFP accumulation in Cofilin-GFP-transduced Clone 4 CTLs and TILs from the indicated mice after 
interacting with HA peptide pulsed Renca+HA cells. Data are means ± SEM from computational analysis of 
the microscopy data the data in fig. S4B and Fig. 8B. *P<0.05, **P< 0.01 (C), **P< 0.0045 (D and E, to 
account for Bonferroni correction), ***P< 0.001, ****P< 0.0001 by proportion’s z-test (A and B), Kruskall-






Fig. S8.  Acute in vitro blockade of PD-1 does not restore cytoskeletal polarization. (A and B) Microscopy 
analysis of HA-specific CTLs and TILs interacting with HA peptide pulsed Renca+HA cells in the presence of 
antibody against PD-1, as indicated. Percentage of cells with off-synapse lamellae (A) and time of first off-
synapse lamella (B) are means ± 95% confidence interval from computational analysis of the microscopy 
data in Fig. 2, F and G, and Fig. 9B. (C) Analysis of relative enrichment of F-tractin-GFP in the 10% of the 
cell volume with the most intense F-tractin-GFP accumulation in F-tractin-GFP-transduced Clone 4 CTLs 
and TILs in the presence of antibody against PD-1 after interaction with HA peptide pulsed Renca+HA cells. 
Data are means ± SEM from computational analysis of the microscopy data in Fig. 3E and Fig. 9C.  **P< 






Fig. S9. Data pooling. Data of the indicated number of independent experimental repeats (‘expt’) with the 
indicated number of cell couples analyzed (‘n’) are given for three representative data sets comparing 
CTLs (on the left) with TILs (on the right), (A) time until off-interface lamella (to Fig. 2G), (B) cofilin 
enrichment at the cellular interface (to Fig. S4B), and (C) elevation of the cytoplasmic calcium 
concentration (to Fig. 5D). Shown are individual measurements with mean ± 95% confidence interval (A) 
or means ± 95% confidence interval (B and C).  
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Movie S1. Representative interactions of a tubulin-GFP transduced Clone 4 CTL and TIL with Renca+HA 
target cells. DIC images are shown on the top, with matching top-down, maximum projections of 3D 
sensor fluorescence data on the bottom. The sensor fluorescence intensity is displayed in a rainbow-like, 
false-color scale (increasing from blue to red). 20 s intervals in video acquisition are played back as 2 
frames per second. The Clone 4 CTL and TIL in Movie S1 are transduced with tubulin-GFP. The movie starts 
with the CTL interaction with cell coupling occurring on top of the image in frame 8. The TIL interaction 
follows with cell coupling occurring in frame 6 of the TIL part. 
 
Movie S2. Representative interactions of a F-tractin-GFP transduced Clone 4 CTL, TIL, and CTL in the 
presence of Japlakinolide with Renca+HA target cells. The Clone 4 CTLs and TIL in Movie S3 are transduced 
with F-tractin-GFP. The movie starts with the CTL interaction with cell coupling occurring in frame 4. The 
TIL interaction follows with cell coupling occurring in frame 8 of the TIL part. The CTL interaction in the 
presence of 40nM Jasplakinolide follows with cell coupling occurring in frame 9. 
 
Movie S3. Representative interactions of a cofilin-GFP transduced Clone 4 CTL and TIL with  Renca+HA 
target cells. The Clone 4 CTL and TIL in Movie S3 are transduced with cofilin-GFP. The movie starts with 
the CTL interaction with cell coupling occurring on top of the image in frame 4. The TIL interaction follows 
with cell coupling occurring in frame 3 of the TIL part. 
 
Movie S4 Representative interaction of a Coronin 1A-GFP transduced Clone 4 CTL with a Renca+HA target 
cell. The Clone 4 CTL in Movie S4 is transduced with Coronin 1A-GFP. Cell coupling occurs in frame 3. 
 
Movie S5 Representative interactions of an Arp3-GFP transduced Clone 4 CTL and TIL with Renca+HA 
target cells. The Clone 4 CTL and TIL in Movie S5 are transduced with Arp3-GFP. The movie starts with the 
CTL interaction with cell coupling occurring on top of the image in frame 3. The TIL interaction follows 
with cell coupling occurring in frame 4 of the TIL part. 
 
Movie S6 Representative interaction of a Chronophin-GFP transduced Clone 4 CTL with a Renca+HA target 
cell. The Clone 4 CTL in Movie S6 is transduced with Chronophin-GFP. Cell coupling occurs in frame 6. 
 
Movie S7. Representative interactions of a Fura-2 -loaded Clone 4 CTL and TIL with a Renca+HA target 
cells. The Clone 4 CTL and TIL in Movie S12 are Fura-2-loaded. The ratio of Fura-2 emission upon excitation 
with 340nm over 380nm is given with a false color intensity scale (blue to red). 10 s intervals in video 
acquisition are played back as 2 frames per second. The movie starts with the CTL interaction with cell 
coupling occurring on top of the image in frame 20. The TIL interaction follows with cell coupling occurring 
in frame 42 of the TIL part. 
 
